Compositions and methods for polynucleotide sequencing

US10364462B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10364462-B2
Application numberUS-201715606354-A
CountryUS
Kind codeB2
Filing dateMay 26, 2017
Priority dateNov 26, 2013
Publication dateJul 30, 2019
Grant dateJul 30, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and compositions for characterizing a target polynucleotide, including, characterizing the sequence of the target polynucleotide, using the fractional translocation steps of the target polynucleotide's translocation through a pore.

First claim

Opening claim text (preview).

What is claimed is: 1. A system for characterizing a target polynucleotide, comprising: a polypeptide pore inserted into a membrane having a cis and a trans surface; a Hel308 helicase contacting the pore on the cis surface of the membrane; a solution comprising a target polynucleotide and less than 1 mM ATP or analogue thereof contacting the cis surface of the membrane; an amplifier adapted to provide a potential difference across the membrane; a processor with instructions to characterize signals from fractional step translocations of the polynucleotide through the polypeptide pore; and a detector adapted to measure an ionic current flowing through the pore. 2. The system of claim 1 , wherein the instructions are adapted to characterize at least two signals during a full translocation cycle of the Hel308 helicase. 3. The system of claim 1 , wherein the instructions comprise a Hidden Markov model. 4. The system of claim 1 , wherein the detector is adapted to measure at least two signals during a full translocation cycle of the Hel308 helicase. 5. The system of claim 1 , wherein the detector measures a current response at a sampling rate of about 50 kHz. 6. The system of claim 1 , wherein the polypeptide pore comprises a constriction zone with a length that can hold no more than five nucleotides. 7. The system of claim 1 , wherein the polypeptide pore comprises a constriction zone with a length that can hold no more than two nucleotides. 8. The system of claim 1 , wherein the solution comprises less than about 100 μM ATP or analogue thereof. 9. The system of claim 1 , wherein the polypeptide pore comprises a Mycobacterium smegmatis porin A (MspA) pore. 10. The system of claim 1 , wherein the polypeptide pore comprises a wild type MspA polypeptide comprising one or more mutations selected from the group consisting of D90N, D91N, D93N, D118R, D134R and E139K. 11. The system of claim 1 , wherein the polypeptide pore comprises an amino acid sequence having at least about 90% homology to SEQ ID NO: 1. 12. The system of claim 1 , wherein the polypeptide pore comprises an amino acid sequence of SEQ ID NO: 1. 13. The system of claim 1 , wherein the Hel308 helicase comprises a motif having an amino acid sequences selected from the group consisting of SEQ ID NO:04-65. 14. The system of claim 1 , wherein the membrane comprises a lipid bilayer. 15. The system of claim 14 , wherein the lipid bilayer comprises 1,2-diphytanoyl-sn-glycero-3-phosphocholine. 16. A method of characterizing a target polynucleotide, the method comprising: (a) obtaining the system of claim 1 ; (b) applying a potential difference across a pore in contact with a Hel308 helicase and the target polynucleotide; (c) measuring at least two signals for a unit of one or more nucleotides of the target polynucleotide moving through the pore during a full translocation cycle of the Hel308 helicase; and (d) characterizing the target polynucleotide using the at least two signals measured in (c). 17. The method of claim 16 , wherein the at least two signals comprise electrical signals. 18. The method of claim 16 , further comprising repeating steps (b) (d). 19. The method of claim 16 , wherein a full translocation cycle of the Hel308 helicase comprises nucleotide substrate binding and nucleotide substrate hydrolysis.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10364462B2 cover?
Methods and compositions for characterizing a target polynucleotide, including, characterizing the sequence of the target polynucleotide, using the fractional translocation steps of the target polynucleotide's translocation through a pore.
Who is the assignee on this patent?
Illumina Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6869. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).